Why the study?
Does ramipril prevent ischemic heart disease, improve myocardial function in adolescents, and delay nephropathy progression?
Does ramipril prevent ischemic heart disease, improve myocardial function in adolescents, and delay nephropathy progression?
This review highlights the broad cardioprotective and nephroprotective benefits of ramipril across various patient populations.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Supports ramipril consideration in IHD and nephropathy; leaves open prospective validation in adolescents.
There is grate interest to ACE inhibitors which have cardioprotective and neproprotective effects. Ramipril efficacy in ischemic heart disease prevention as well as ramipril positive effect on myocardium in adolescents is presented on the base of some trails. Ramipril ability to delay of diabetic and non-diabetic nephropathy progression is also discussed.
Напалков et al. (2009) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: